Metformin Versus Empagliflozin Monotherapy on Short-Term Glycemic Dairy: A true Experimental Study
Barakat Wathiq Alawdi; Jasem Hanoon Hashim Al-Awadi; Abdulhamza Rajooj Hmood Al-Ameri
Background: Glycemic control is still the most important aspect of T2DM treatment sodium-glucose cotransporter-2 (SGLT2) inhibitor, empagliflozin, and metformin therapy has been shown to be effective and well tolerated in patients with...